News
Humedica poised for success in health data sector
June 28, 2010 10:37 am | by Mass High Tech: The Journal of New England Technology | CommentsData that help doctors and life sciences companies improve patient care and reduce costs will be their most valuable asset in five years, according to a survey by PricewaterhouseCoopers. If so, then Boston-based Humedica, Inc. stands to be a big winner.
Recondo Technology Announces Integration Initiative for US Hospital Systems
June 28, 2010 10:37 am | by Bio-Medicine.Org | CommentsGREENWOOD VILLAGE, Colo. , June 28 /- Recondo Technology, a leading provider of revenue cycle solutions for the healthcare industry, announced today the general availability of a suite of tools and services to integrate various and disparate hospital systems, applications, software...
Mr. Jean-Pierre Garnier Concludes his Mission at the Pierre Fabre Company
June 28, 2010 10:36 am | by Bio-Medicine.Org | CommentsCASTRES, France , June 28, 2010 /- Mr Jean-Pierre Garnier will step down on September 1st 2010, two years after having been appointed CEO of the Pierre Fabre Group. "The Company is in excellent health, and is poised to experience a bright future ; I am glad to have contributed to its...
Study Shows Gradual Addition of NovoLog® at Mealtime Can Reduce A1c in Type 2 Diabetes Patients
June 28, 2010 10:36 am | by Bio-Medicine.Org | CommentsORLANDO, Fla. , June 28 /- Today Novo Nordisk announced results of its STEPwise™ trial, which identified a method of intensifying insulin treatment with NovoLog® (insulin aspart [rDNA origin] injection). The study, presented at the American Diabetes Association (ADA) 2010...
Ortho-McNeil-Janssen Pharmaceuticals, Inc. Announces Oncology Research Collaboration Agreement with the Koch Institute for Integrative Cancer Research at MIT
June 28, 2010 10:34 am | by Bio-Medicine.Org | CommentsRARITAN, N.J. , June 28 /- Ortho-McNeil-Janssen Pharmaceuticals, Inc. today announced the signing of a five-year collaboration agreement with the David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology . Called TRANSCEND, the...
Abbott Receives FDA Clearance for Molecular Diagnostic Test for Detection of Chlamydia and Gonorrhea Infections
June 28, 2010 10:34 am | by Bio-Medicine.Org | CommentsDES PLAINES, Ill. , June 28 /- Abbott (NYSE: ABT ) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect two of the nation's most prevalent sexually...
Global Acute Coronary Syndrome Industry
June 28, 2010 10:34 am | by Bio-Medicine.Org | CommentsNEW YORK , June 28 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Acute Coronary Syndrome industry http://www.reportlinker.com/p0197235/Global-Acute-Coronary-Syndrome-indu... This report analyzes the globa...
Studies of women's attitudes to 'social egg freezing' find reasons differ with age
June 28, 2010 8:34 am | by EurekAlert | Comments(European Society of Human Reproduction and Embryology) Women of different ages differ in their reasons for wishing to undergo egg freezing, show two studies presented to the 26th annual meeting of the European Society of Human Reproduction and Embryology today.
Endometriosis has a significant effect on women's work productivity, first
June 28, 2010 8:34 am | by EurekAlert | Comments(European Society of Human Reproduction and Embryology) The first worldwide study of the societal impact of endometriosis has found a significant loss of work productivity among those women who suffer from the condition.
Overweight women undertaking ART twice as likely to miscarry as their slimmer counterparts
June 28, 2010 8:34 am | by EurekAlert | Comments(European Society of Human Reproduction and Embryology) Being overweight leads to a greater risk of miscarriage for patients undergoing assisted reproductive technology, the 26th annual conference of the European Society of Human Reproduction and Embryology heard today. Dr. Vivian...
Screening for transmissible disease in ART patients not necessary at each donation
June 28, 2010 8:34 am | by EurekAlert | Comments(European Society of Human Reproduction and Embryology) European legislation that requires all couples undergoing assisted reproduction treatment to be screened for HIV and hepatitis at the time of every sperm or egg donation is unnecessary, expensive, and potentially distressing...
Forma Therapeutics, Emerald BioStructures partner over drug development
June 28, 2010 8:33 am | by Mass High Tech: The Journal of New England Technology | CommentsCambridge small-molecule therapeutics developer Forma Therapeutics Inc. has partnered with Emerald BioStructures for the structure-based development of potential cancer drug targets.
Memories are made of this
June 28, 2010 7:35 am | by EurekAlert | Comments(University of Leicester) A new Wellcome Trust-funded study led by University of Leicester uncovers the key to how we learn and remember.
Tianyin Promotes its Flagship Product Portfolio at the 45th 2010 National New Special Drugs Trade Fair in July at Beijing
June 28, 2010 7:32 am | by Bio-Medicine.Org | CommentsCHENGDU, China , June 28 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical (NYSE Amex: TPI ), a biopharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine and branded generics will exhibit and promote its flagship product...
International study identifies 12 new genetic risk factors for type 2 diabetes
June 28, 2010 6:38 am | by EurekAlert | Comments(Helmholtz Zentrum München - German Research Center for Environmental Health) An international consortium including Helmholtz Zentrum Muenchen and the German Diabetes Center, Duesseldorf, has identified 12 new gene variants which impact the individual's risk of developing type 2...
